Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 mai 2018 08h32 HE | Source: Esperite N.V.

Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn's disease.

Amsterdam, The Netherlands -17th May 2018 Esperite's The Cell Factory has signed today the agreement with PHARM, the Italian CRO company which is preparing for the first-in-man clinical trials...
17 mai 2018 01h17 HE | Source: Esperite N.V.

ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today

Amsterdam, The Netherlands - 17 May 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 18th Tranche of EUR 400,000 is issued as a private placement of 40...
16 mai 2018 03h31 HE | Source: Esperite N.V.

ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION

Amsterdam, the Netherlands - 16 May 2018 Esperite NV, The Regenerative and predictive medicine company has acquired control of its long-term South African joint venture CryoSave South Africa Ltd....
03 mai 2018 05h36 HE | Source: Esperite N.V.

Esperite's (ESP) The Cell Factory received European funding to develop the 2nd generation EVs drug for treatment of Stroke

Esperite's biotech company The Cell Factory, Belgium has received funding from the European Union's Horizon 2020 research and innovation Programme for development and characterization of the...
30 avr. 2018 06h55 HE | Source: Esperite N.V.

ESPERITE NV (ESP) delays publication of Annual Report 2017

Amsterdam, The Netherlands - 30 April 2018 Esperite regrets to announce that due to technical issues and despite the constant efforts provided by the different teams involved, the publication of...
11 avr. 2018 01h17 HE | Source: Esperite N.V.

ESPERITE (ESP): EUR 1,200,000 of new funding provided by European Select Growth Opportunities Fund until May 25, 2018.

Continuation of support to Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines Amsterdam, The Netherlands -...
29 mars 2018 03h14 HE | Source: Esperite N.V.

Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases

Esperite with its biotech company The Cell Factory has acquired from OPBG the full rights to the IP and the international patent family covering the invention and the therapeutic use of the EV's...
02 mars 2018 01h17 HE | Source: Esperite N.V.

ESPERITE (ESP) : L1 Capital subscribes to the 16th tranche of investment today

Amsterdam, The Netherlands - 2 March 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 16th Tranche of EUR 250,000 is issued as a private placement of 25...
16 févr. 2018 01h17 HE | Source: Esperite N.V.

ESPERITE (ESP): EUR 500,000 of new funding provided by European Select Growth Opportunities Fund until March 2, 2018.

Continuation of support to Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines Amsterdam, The Netherlands -...
31 janv. 2018 07h26 HE | Source: Esperite N.V.

ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale.

Esperite with BGI sequencing technology will enable the global population easier access to the gold standard in clinical genetic testing. Amsterdam, The Netherlands - 31 January 2018 BGI is the...

Page précédente

Page suivante